Latest News about INCY
Recent news which mentions INCY
Incyte Gets FDA Nod For Hematologic Malignancies Candidate
August 26, 2022
Tickers
INCY
From Benzinga
4 Growth Stocks to Buy and Hold Forever
August 12, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
August 03, 2022
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Twitter And 3 Other Stocks Insiders Are Selling
July 12, 2022
From Benzinga
From Motley Fool
From Benzinga
7 Defensive Stocks to Buy for a Bear Market
June 27, 2022
Tags
LLY
Market News
NYSE:ADM,NYSE:CPB,NYSE:KO,NYSE:ED,NYSE:LLY,NYSE:KMB,NYSE:LMT,NASDAQ:INCY,NYSE:MKC
From InvestorPlace
7 Defensive Stocks to Buy for a Bear Market
June 27, 2022
Tags
LLY
NYSE:ADM,NYSE:CPB,NYSE:KO,NYSE:ED,NYSE:LLY,NYSE:KMB,NYSE:LMT,NASDAQ:INCY,NYSE:MKC
Market News
From InvestorPlace
From Motley Fool
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
June 14, 2022
From Benzinga
From Benzinga
From Benzinga
Lilly-Incyte Snag FDA Nod For Patchy Hair Loss Treatment — Smaller Rival's Stock Shoots Up In Sympathy
June 14, 2022
From Benzinga
From MarketWatch
From Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2022
May 18, 2022
From Motley Fool
From Motley Fool
From Benzinga
Why CTI Biopharma Stock Is Surging Today
May 13, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.